Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Rocket Pharmaceuticals, Inc. Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $92.2 Billion
- Q3 2024
A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 12,006 shares of RCKT stock, worth $127,023. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,006
Previous 13,118
8.48%
Holding current value
$127,023
Previous $282,000
21.63%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding RCKT
# of Institutions
210Shares Held
93MCall Options Held
319KPut Options Held
70.3K-
Rtw Investments, LP New York, NY17.7MShares$187 Million5.21% of portfolio
-
Wellington Management Group LLP Boston, MA11.2MShares$119 Million0.04% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$65.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.54MShares$58.6 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.49MShares$47.5 Million0.39% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $801M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...